AV-101 Alone and in Combination With Probenecid in Healthy Subjects

Recruiting

Phase 1

AV-101 & ProbenecidAV-101 Alone and in Combination With Probenecid in Healthy Subjects

Sponsor:

VistaGen Therapeutics, Inc.

Code:

NCT05280054

Conditions

Drug Drug Interaction

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Accepted

Interventions

AV-101

Probenecid

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by VistaGen Therapeutics, Inc. on 2022-03-15.